• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOZART,一种基于网络的多靶标定量构效关系工具,可预测多种药物-酶相互作用。

MOZART, a QSAR Multi-Target Web-Based Tool to Predict Multiple Drug-Enzyme Interactions.

机构信息

LAQV@REQUIMTE/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.

CINBIO, Department of Computer Science, ESEI-Escuela Superior de Ingeniería Informática, Universidade de Vigo, 32004 Ourense, Spain.

出版信息

Molecules. 2023 Jan 25;28(3):1182. doi: 10.3390/molecules28031182.

DOI:10.3390/molecules28031182
PMID:36770857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9921108/
Abstract

Developing models able to predict interactions between drugs and enzymes is a primary goal in computational biology since these models may be used for predicting both new active drugs and the interactions between known drugs on untested targets. With the compilation of a large dataset of drug-enzyme pairs (62,524), we recognized a unique opportunity to attempt to build a novel multi-target machine learning (MTML) quantitative structure-activity relationship (QSAR) model for probing interactions among different drugs and enzyme targets. To this end, this paper presents an MTML-QSAR model based on using the features of topological drugs together with the artificial neural network (ANN) multi-layer perceptron (MLP). Validation of the final best model found was carried out by internal cross-validation statistics and other relevant diagnostic statistical parameters. The overall accuracy of the derived model was found to be higher than 96%. Finally, to maximize the diffusion of this model, a public and accessible tool has been developed to allow users to perform their own predictions. The developed web-based tool is public accessible and can be downloaded as free open-source software.

摘要

开发能够预测药物与酶之间相互作用的模型是计算生物学的主要目标,因为这些模型可用于预测新的活性药物以及已知药物在未经测试的靶标上的相互作用。通过编译一个包含大量药物-酶对(62524 对)的数据集,我们认识到这是一个独特的机会,可以尝试构建一种新的多靶机器学习(MTML)定量构效关系(QSAR)模型,以探究不同药物和酶靶标之间的相互作用。为此,本文提出了一种基于拓扑药物特征与人工神经网络(ANN)多层感知器(MLP)的 MTML-QSAR 模型。通过内部交叉验证统计和其他相关诊断统计参数对最终最佳模型进行了验证。所得到的模型的整体准确性被发现高于 96%。最后,为了最大限度地推广该模型,我们开发了一个公共且可访问的工具,允许用户进行自己的预测。开发的基于网络的工具是公共可访问的,可以作为免费的开源软件下载。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/4471f390f476/molecules-28-01182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/175bf1658592/molecules-28-01182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/378c6068a4da/molecules-28-01182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/4471f390f476/molecules-28-01182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/175bf1658592/molecules-28-01182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/378c6068a4da/molecules-28-01182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f6/9921108/4471f390f476/molecules-28-01182-g003.jpg

相似文献

1
MOZART, a QSAR Multi-Target Web-Based Tool to Predict Multiple Drug-Enzyme Interactions.MOZART,一种基于网络的多靶标定量构效关系工具,可预测多种药物-酶相互作用。
Molecules. 2023 Jan 25;28(3):1182. doi: 10.3390/molecules28031182.
2
NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.NL MIND-BEST:一个用于配体和蛋白质发现的网络服务器——理论-实验研究蓝氏贾第鞭毛虫蛋白和新的抗疟化合物。
J Theor Biol. 2011 May 7;276(1):229-49. doi: 10.1016/j.jtbi.2011.01.010. Epub 2011 Jan 26.
3
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.2D MI-DRAGON:一种新的蛋白配体相互作用预测因子,以及美国 FDA 药物靶点网络、MAO-A 抑制剂和人体寄生虫蛋白的理论-实验研究。
Eur J Med Chem. 2011 Dec;46(12):5838-51. doi: 10.1016/j.ejmech.2011.09.045. Epub 2011 Oct 1.
4
3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.3D MI-DRAGON:用于构建美国食品和药物管理局药物-靶标网络的新模型,以及针对 AChE 的 rasagiline 衍生物抑制剂的理论-实验研究。
Curr Top Med Chem. 2012;12(16):1843-65.
5
Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.利用药物和蛋白质网络图的熵预测 FDA 药物-靶标网络:单胺氧化酶抑制剂和来自 Fasciola hepatica 的血红蛋白肽的理论-实验研究。
Eur J Med Chem. 2011 Apr;46(4):1074-94. doi: 10.1016/j.ejmech.2011.01.023. Epub 2011 Jan 21.
6
ADis-QSAR: a machine learning model based on biological activity differences of compounds.ADis-QSAR:一种基于化合物生物活性差异的机器学习模型。
J Comput Aided Mol Des. 2023 Sep;37(9):435-451. doi: 10.1007/s10822-023-00517-1. Epub 2023 Jun 29.
7
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
8
Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.抗菌剂的统一定量构效关系方法。第3部分:用于抗原生动物化合物的输入编码预测、结构反向投影和复杂网络聚类的首个多任务定量构效关系模型。
Bioorg Med Chem. 2008 Jun 1;16(11):5871-80. doi: 10.1016/j.bmc.2008.04.068. Epub 2008 Apr 29.
9
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.用复杂网络拓扑指数预测寄生虫感染中的药物和蛋白质:理论背景、应用和法律问题。
Curr Pharm Des. 2010;16(24):2737-64. doi: 10.2174/138161210792389234.
10
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.抗菌剂的统一定量构效关系方法。4. 抗病毒药物 - 药物复合网络巨型组件的多靶点定量构效关系建模与比较多距离研究。
Bioorg Med Chem. 2009 Jan 15;17(2):569-75. doi: 10.1016/j.bmc.2008.11.075. Epub 2008 Dec 6.

本文引用的文献

1
Targeting highly resisted anticancer drugs through topological descriptors using VIKOR multi-criteria decision analysis.使用VIKOR多准则决策分析,通过拓扑描述符靶向高度抗药的抗癌药物。
Eur Phys J Plus. 2022;137(11):1245. doi: 10.1140/epjp/s13360-022-03469-x. Epub 2022 Nov 15.
2
New Computational Approaches Aimed at the Prediction of More Selective and Active Drugs.旨在预测更具选择性和活性药物的新计算方法。
Curr Top Med Chem. 2020;20(18):1581. doi: 10.2174/156802662018200630150100.
3
A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
多层变量选择策略在丁酰胆碱酯酶抑制剂 QSAR 建模中的应用。
Curr Top Med Chem. 2020;20(18):1601-1627. doi: 10.2174/1568026620666200616142753.
4
Developing a Multi-target Model to Predict the Activity of Monoamine Oxidase A and B Drugs.开发一个多靶点模型来预测单胺氧化酶 A 和 B 类药物的活性。
Curr Top Med Chem. 2020;20(18):1593-1600. doi: 10.2174/1568026620666200603121224.
5
Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs.定量构效关系(QSAR)研究对单胺氧化酶的抑制作用。
Comb Chem High Throughput Screen. 2020;23(9):887-897. doi: 10.2174/1386207323666200324173231.
6
The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation.马修斯相关系数(MCC)在二分类评估中优于 F1 得分和准确率的优势。
BMC Genomics. 2020 Jan 2;21(1):6. doi: 10.1186/s12864-019-6413-7.
7
Alignment-Free Method to Predict Enzyme Classes and Subclasses.无比对方法预测酶类和亚类。
Int J Mol Sci. 2019 Oct 29;20(21):5389. doi: 10.3390/ijms20215389.
8
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges.通过受扰静电势电荷对 MEK4 激酶抑制剂进行建模。
J Chem Inf Model. 2019 Oct 28;59(10):4460-4466. doi: 10.1021/acs.jcim.9b00490. Epub 2019 Oct 14.
9
Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.醛脱氢酶抑制剂在癌症治疗中的应用。
Trends Pharmacol Sci. 2019 Oct;40(10):774-789. doi: 10.1016/j.tips.2019.08.002. Epub 2019 Sep 9.
10
Combined QSAR Model and Chemical Similarity Search for Novel HMGCoA Reductase Inhibitors for Coronary Heart Disease.联合 QSAR 模型和化学相似性搜索新型用于治疗冠心病的 HMG-CoA 还原酶抑制剂。
Curr Comput Aided Drug Des. 2020;16(4):473-485. doi: 10.2174/1573409915666190904114247.